# Human Salivary Gland Disposition of Alda-341 in Patients Undergoing Salivary Gland Surgery

> **NCT04296266** · EARLY_PHASE1 · COMPLETED · sponsor: **Stanford University** · enrollment: 10 (actual)

## Conditions studied

- Submandibular Gland Tumor
- Parotid Gland Tumor

## Interventions

- **DRUG:** Alda-341

## Key facts

- **NCT ID:** NCT04296266
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02
- **Primary completion:** 2017-12-18
- **Final completion:** 2017-12-21
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2020-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04296266

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04296266, "Human Salivary Gland Disposition of Alda-341 in Patients Undergoing Salivary Gland Surgery". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04296266. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*